Guy Leverger

13.6k total citations
242 papers, 6.0k citations indexed

About

Guy Leverger is a scholar working on Hematology, Public Health, Environmental and Occupational Health and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Guy Leverger has authored 242 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 102 papers in Hematology, 93 papers in Public Health, Environmental and Occupational Health and 61 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Guy Leverger's work include Acute Lymphoblastic Leukemia research (82 papers), Acute Myeloid Leukemia Research (57 papers) and Childhood Cancer Survivors' Quality of Life (51 papers). Guy Leverger is often cited by papers focused on Acute Lymphoblastic Leukemia research (82 papers), Acute Myeloid Leukemia Research (57 papers) and Childhood Cancer Survivors' Quality of Life (51 papers). Guy Leverger collaborates with scholars based in France, United States and Netherlands. Guy Leverger's co-authors include André Baruchel, Anne Auvrignon, Brigitte Nelken, Thierry Leblanc, Jacqueline Clavel, Denis Hémon, Yves Pérel, G Schaison, Yves Bertrand and Virginie Gandemer and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Guy Leverger

232 papers receiving 5.8k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Guy Leverger 2.7k 1.9k 1.2k 1.1k 1.1k 242 6.0k
Agnès Buzyn 3.0k 1.1× 1.9k 1.0× 822 0.7× 669 0.6× 1.5k 1.4× 137 5.7k
Bruce Bostrom 2.1k 0.8× 2.9k 1.5× 1.2k 1.0× 1.9k 1.7× 1.1k 1.0× 129 6.0k
Liisa Volin 4.6k 1.7× 1.4k 0.7× 938 0.8× 570 0.5× 1.8k 1.7× 210 7.0k
Yves Chalandon 2.3k 0.8× 1.4k 0.7× 494 0.4× 623 0.5× 995 0.9× 192 4.3k
R Zittoun 3.1k 1.2× 1.9k 1.0× 2.0k 1.6× 647 0.6× 2.5k 2.3× 231 6.8k
H. Löffler 2.6k 1.0× 1.4k 0.7× 1.0k 0.8× 318 0.3× 1.0k 1.0× 212 6.0k
Emmanuel Raffoux 4.4k 1.6× 1.9k 1.0× 3.0k 2.5× 512 0.5× 1.7k 1.6× 193 7.7k
Alan S. Gamis 3.1k 1.2× 1.7k 0.9× 1.6k 1.4× 696 0.6× 1.1k 1.0× 222 5.0k
Ajay Vora 3.3k 1.2× 4.5k 2.3× 887 0.7× 2.8k 2.5× 1.3k 1.2× 184 6.7k
Rainer Schwerdtfeger 4.3k 1.6× 1.2k 0.6× 534 0.4× 481 0.4× 1.4k 1.3× 126 6.0k

Countries citing papers authored by Guy Leverger

Since Specialization
Citations

This map shows the geographic impact of Guy Leverger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy Leverger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy Leverger more than expected).

Fields of papers citing papers by Guy Leverger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy Leverger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy Leverger. The network helps show where Guy Leverger may publish in the future.

Co-authorship network of co-authors of Guy Leverger

This figure shows the co-authorship network connecting the top 25 collaborators of Guy Leverger. A scholar is included among the top collaborators of Guy Leverger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy Leverger. Guy Leverger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Saultier, Paul, Gérard Michel, Anne Sîrvent, et al.. (2023). Chronic Graft-Versus-Host Disease in Long-Term Survivors of Childhood Leukemia. Blood. 142(Supplement 1). 3762–3762. 1 indexed citations
2.
Lapillonne, Hélène, Meyling Cheok, Claude Preudhomme, et al.. (2022). Prognostic impact of ABCA3 expression in adult and pediatric acute myeloid leukemia: an ALFA-ELAM02 joint study. Blood Advances. 6(9). 2773–2777. 5 indexed citations
3.
Minard‐Colin, Véronique, Nadège Corradini, Guy Leverger, et al.. (2021). Extracranial rhabdoid tumours: Results of a SFCE series of patients treated with a dose compression strategy according to European Paediatric Soft tissue sarcoma Study Group recommendations. European Journal of Cancer. 161. 64–78. 11 indexed citations
4.
Fenneteau, Odile, et al.. (2021). Infant Acute Myeloid Leukemia: A Unique Clinical and Biological Entity. Cancers. 13(4). 777–777. 14 indexed citations
5.
Vercasson, Camille, Pascal Auquier, Gérard Michel, et al.. (2020). Quality of life in parents of childhood leukemia survivors. A French Childhood Cancer Survivor Study for Leukemia study. Pediatric Blood & Cancer. 67(10). e28419–e28419. 12 indexed citations
6.
Ducassou, Stéphane, Helder Fernandes, Hélène Savel, et al.. (2020). Prospective Evaluation of the First Option, Second-Line Therapy in Childhood Chronic Immune Thrombocytopenia: Splenectomy or Immunomodulation. The Journal of Pediatrics. 231. 223–230. 1 indexed citations
8.
Fenneteau, Odile, et al.. (2019). Contribution of Bone Marrow Examination in the Diagnosis of Pediatric Pathologies at the Mother and Child Center of Chantal Biya Foundation. Health sciences and disease. 20(2). 1 indexed citations
9.
Rabian, Florence, Hélène Boutroux, Marion Strullu, et al.. (2019). Azacitidine in Pediatric Hematologic Myeloid Malignancies: A Retrospective Study. Blood. 134(Supplement_1). 5130–5130.
10.
Frazer, J. Kimble, Kevin J. Li, Paul J. Galardy, et al.. (2018). Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B‐NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1. British Journal of Haematology. 185(2). 374–377. 14 indexed citations
11.
Guitard, J., F Isnard, Marie‐Dominique Tabone, et al.. (2018). Usefulness of ß-D-glucan for diagnosis and follow-up of invasive candidiasis in onco-haematological patients. Journal of Infection. 76(5). 483–488. 19 indexed citations
12.
Petit, Arnaud, Amélie Trinquand, Sylvie Chevret, et al.. (2017). Oncogenetic mutations combined with MRD improve outcome prediction in pediatric T-cell acute lymphoblastic leukemia. Blood. 131(3). 289–300. 61 indexed citations
13.
Pierron, Gaëlle, Paul Fréneaux, Sophie Huybrechts, et al.. (2017). NUT carcinoma in children and adults: A multicenter retrospective study. Pediatric Blood & Cancer. 64(12). 64 indexed citations
14.
Kaspers, Gertjan J.L., Martin Zimmermann, Dirk Reinhardt, et al.. (2013). Improved Outcome in Pediatric Relapsed Acute Myeloid Leukemia: Results of a Randomized Trial on Liposomal Daunorubicin by the International BFM Study Group. Journal of Clinical Oncology. 31(5). 599–607. 152 indexed citations
15.
Aladjidi, Nathalie, Raoul Santiago, Corinne Pondarré, et al.. (2012). Revisiting Splenectomy in Childhood Immune Thrombocytopenic Purpura in the Era of New Therapies: The French Experience. Journal of Blood Disorders & Transfusion. s3. 5 indexed citations
16.
Bally, Cécile, Jehane Fadlallah, Guy Leverger, et al.. (2012). Outcome of Acute Promyelocytic Leukemia (APL) in Children and Adolescents: An Analysis in Two Consecutive Trials of the European APL Group. Journal of Clinical Oncology. 30(14). 1641–1646. 32 indexed citations
17.
Orsi, Laurent, Guy Leverger, André Baruchel, et al.. (2010). Road Traffic and Childhood Leukemia: The ESCALE Study (SFCE). Environmental Health Perspectives. 119(4). 566–572. 61 indexed citations
18.
Rudant, Jérémie, F. Ménégaux, Guy Leverger, et al.. (2007). Household Exposure to Pesticides and Risk of Childhood Hematopoietic Malignancies: The ESCALE Study (SFCE). Environmental Health Perspectives. 115(12). 1787–1793. 70 indexed citations
19.
Cordonnier, Charlotte, Guy Leverger, Benoı̂t Schlemmer, et al.. (1994). [Antibiotic strategy for febrile episodes during severe (less than 500 PNN) and prolonged (greater than or equal to 7 days) neutropenia. Recommendations of the Evaluation Committee of the Collège Français des Hematologistes].. PubMed. 36(4). 289–91. 1 indexed citations
20.
Fischer, Alain, Nadine Cerf–Bensussan, Stéphane Blanche, et al.. (1986). Allogeneic bone marrow transplantation for erythrophagocytic lymphohistiocytosis. The Journal of Pediatrics. 108(2). 267–270. 116 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026